The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

There is mild anticipation that as the Snake year slithers in, the local IPO markets will open up, and the STI will hit a new ...

Taking a more bearish stance, CLSA has downgraded HUL to an Underperform rating. The brokerage firm also has slashed its ...

Out of the 43 analysts that now have coverage on HUL, 27 of them have maintained a 'Buy' rating on the stock, while 13 of ...

Confusion among strategists evidenced by outlook for interest rates; S-REITs staying lethargic; data centres in focus ...

SK Hynix Inc. reported a record quarterly profit after the company extended its lead in advanced memory chips for datacenters ...

SK Hynix Inc.’s shares slid 4.7% after its record quarterly profit and modest capex plans failed to impress investors betting ...

For Q3FY25, HUL reported a net profit of Rs 3,001 crore, exceeding estimates, although profit before exceptional items (PAT ...

BYD COMPANY (01211.HK) toppled Toyota for the first time in 2024 to become the most popular car brand in Singapore, foreign ...